Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma

Gliomas appear to be highly immunosuppressive tumors, with a strong myeloid component. This includes MDSCs, which are a heterogeneous, immature myeloid cell population expressing myeloid markers Siglec-3 (CD33) and CD11b and lacking markers of mature myeloid cells including MHC II. Siglec-3 is a mem...

Descripción completa

Detalles Bibliográficos
Autores principales: Santegoets, Kim C. M., Gielen, Paul R., Büll, Christian, Schulte, Barbara M., Kers-Rebel, Esther D., Küsters, Benno, Bossman, Sandra A. J. F. H., ter Laan, Mark, Wesseling, Pieter, Adema, Gosse J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529385/
https://www.ncbi.nlm.nih.gov/pubmed/30953118
http://dx.doi.org/10.1007/s00262-019-02332-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529385/
https://www.ncbi.nlm.nih.gov/pubmed/30953118
http://dx.doi.org/10.1007/s00262-019-02332-w

Ejemplares similares